1. Home
  2. ATAI vs SMTI Comparison

ATAI vs SMTI Comparison

Compare ATAI & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ATAI Life Sciences N.V.

ATAI

ATAI Life Sciences N.V.

HOLD

Current Price

$7.23

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

HOLD

Current Price

$34.31

Market Cap

313.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATAI
SMTI
Founded
2018
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
313.5M
IPO Year
2025
2008

Fundamental Metrics

Financial Performance
Metric
ATAI
SMTI
Price
$7.23
$34.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
2
Target Price
$15.88
$34.00
AVG Volume (30 Days)
17.2M
330.6K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,089,000.00
$15,586,976.00
Revenue This Year
N/A
$17.31
Revenue Next Year
N/A
$12.48
P/E Ratio
N/A
$687.60
Revenue Growth
1227.60
32.47
52 Week Low
$3.27
$16.05
52 Week High
$7.26
$35.70

Technical Indicators

Market Signals
Indicator
ATAI
SMTI
Relative Strength Index (RSI) 71.89 82.56
Support Level $3.89 $20.47
Resistance Level N/A $34.33
Average True Range (ATR) 0.04 0.78
MACD -0.09 0.26
Stochastic Oscillator 68.18 99.12

Price Performance

Historical Comparison
ATAI
SMTI

About ATAI ATAI Life Sciences N.V.

AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

Share on Social Networks: